* Achieve Life Sciences Inc ACHV.OQ reported a quarterly
adjusted loss of 43 cents per share for the quarter ended in
June. The mean expectation of seven analysts for the quarter was
for a loss of 42 cents per share.
* Reported revenue was zero; analysts expected zero.
* Achieve Life Sciences Inc's reported EPS for the quarter
was a
loss of 43 cents.
* The mean earnings estimate of analysts had risen by
about 1% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Achieve Life Sciences Inc shares had risen by 2.3% this
quarter and gained 116.7% so far this year.
* The company reported a quarterly loss of $8.24 million.
* Wall Street's median 12-month price target for Achieve
Life
Sciences Inc is $25.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 14 at 09:03 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.42 -0.43 Missed
Mar. 31 2023 -0.69 -0.50 Beat
Dec. 31 2022 -0.83 -0.83 Met
Sep. 30 2022 -1.13 -1.35 Missed